arXiv ScienceSearch

arXiv subjects

Emma Torrini

Publications and source records attributed to Emma Torrini.

2 recordsLinked to original sources

A Bayesian Approach to Causal Cure Models

Time-to-event data often include individuals who will never experience the failure event, and are therefore considered cured. In such settings, frequently encountered in clinical research, a substantial proportion of patients may remain event-free throughout the observation period, leading to the appearance of a survival plateau that is commonly interpreted as evidence of a cured fraction. Analysing such data requires inference on the cure fraction and on the survival function for the uncured subpopulation, tasks which are traditionally achieved with mixture cure models. However, assessing the causal effect of a treatment on these quantities is non-trivial. We consider principal stratification causal estimands, which have been proposed to evaluate effects on the cure fraction and on the survival for an always-uncured stratum. We additionally introduce a novel estimand, which considers the causal effect on the survival for a non-always-cured union of strata. We frame the problem from a Bayesian model-based perspective, which provides a flexible and unified estimation strategy while maintaining a direct link with classical mixture cure model quantities. The reliability of the proposed approach is validated through simulations, demonstrating competitive and robust performance relative to existing methods. Finally, we illustrate its practical usefulness through an application to a randomized trial comparing non-invasive ventilation with standard oxygen therapy in patients with hypoxemic respiratory failure following abdominal surgery.

stat.ME

Estimating treatment duration effects via clone-censor-weight: a breast cancer case study

In this work, we study the estimation of treatment duration effects in observational survival data, where treatment and covariate histories evolve over time and longer observed durations are only attainable among individuals who remain event-free and under follow-up, leading to immortal time bias under naive analyses. The cloning-censoring-weighting (CCW) framework provides a practical approach to emulate target trials of treatment duration strategies, but several methodological aspects remain insufficiently understood. We focus on static treatment duration strategies under two settings of increasing complexity: baseline confounding only, and confounding with time-varying covariates. We formalize the assumptions underlying CCW, with particular emphasis on treatment admissibility, relaxed intervention rules, and the distinction between artificial and natural censoring. We then compare several estimation approaches after cloning and censoring, including inverse probability of censoring weighting (IPCW), the G-formula, and doubly robust estimators, through simulation studies assessing robustness, variability, and sensitivity to censoring model misspecification. Finally, we apply the framework to a Breast Cancer cohort to emulate a target trial comparing 2 versus 5 years of adjuvant tamoxifen in early stage breast cancer. Due to the small number of events and limited support for the 2-year strategy, estimates are associated with substantial uncertainty. These findings highlight both the practical relevance and the limitations of CCW, and underscore the importance of sensitivity analyses in complex longitudinal observational settings.

stat.ME